Aquabounty Technologies Inc (NASDAQ:AQB) Short Interest Up 7.4% in December

Aquabounty Technologies Inc (NASDAQ:AQB) was the target of a significant growth in short interest in December. As of December 31st, there was short interest totalling 308,900 shares, a growth of 7.4% from the December 15th total of 287,600 shares. Based on an average daily trading volume, of 59,000 shares, the days-to-cover ratio is presently 5.2 days. Approximately 2.7% of the shares of the stock are sold short.

Several large investors have recently added to or reduced their stakes in AQB. BlackRock Inc. boosted its position in shares of Aquabounty Technologies by 95.5% during the 2nd quarter. BlackRock Inc. now owns 51,195 shares of the company’s stock worth $158,000 after acquiring an additional 25,009 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Aquabounty Technologies by 589.8% in the 2nd quarter. Vanguard Group Inc. now owns 420,541 shares of the company’s stock valued at $1,291,000 after purchasing an additional 359,574 shares during the period. Morgan Stanley boosted its position in shares of Aquabounty Technologies by 4.7% in the 2nd quarter. Morgan Stanley now owns 179,028 shares of the company’s stock valued at $550,000 after purchasing an additional 8,041 shares during the period. Nikko Asset Management Americas Inc. boosted its position in shares of Aquabounty Technologies by 17.6% in the 3rd quarter. Nikko Asset Management Americas Inc. now owns 373,874 shares of the company’s stock valued at $935,000 after purchasing an additional 55,949 shares during the period. Finally, Sumitomo Mitsui Trust Holdings Inc. boosted its position in shares of Aquabounty Technologies by 17.6% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 373,874 shares of the company’s stock valued at $935,000 after purchasing an additional 55,949 shares during the period. 61.92% of the stock is owned by institutional investors and hedge funds.

NASDAQ:AQB traded up $0.05 on Thursday, reaching $2.46. The company’s stock had a trading volume of 5,714 shares, compared to its average volume of 71,696. The company has a quick ratio of 5.25, a current ratio of 5.61 and a debt-to-equity ratio of 0.18. The firm has a market cap of $57.47 million, a price-to-earnings ratio of -2.62 and a beta of 1.03. Aquabounty Technologies has a 12-month low of $1.90 and a 12-month high of $5.45. The stock has a 50 day moving average price of $2.21 and a 200 day moving average price of $2.66.

Aquabounty Technologies (NASDAQ:AQB) last posted its quarterly earnings data on Tuesday, November 5th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.17) by $0.03. Aquabounty Technologies had a negative return on equity of 45.56% and a negative net margin of 7,510.69%. Equities research analysts expect that Aquabounty Technologies will post -0.59 EPS for the current fiscal year.

A number of analysts have recently issued reports on the company. Zacks Investment Research lowered Aquabounty Technologies from a “buy” rating to a “hold” rating in a research note on Tuesday. National Securities raised Aquabounty Technologies from a “neutral” rating to a “buy” rating in a research note on Monday. Finally, ValuEngine raised Aquabounty Technologies from a “hold” rating to a “buy” rating in a research note on Wednesday.

Aquabounty Technologies Company Profile

AquaBounty Technologies, Inc, a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc and changed its name to AquaBounty Technologies, Inc in June 2004.

Further Reading: Certificate of Deposit (CD) For Risk Adverse Investors?

Receive News & Ratings for Aquabounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aquabounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.